Abstract: Two lupane and four ursane triterpenes, namely epilupeol (1), lupeol acetate (2), ursolic acid (3), brein (4), 3β 11α-dihydroxy urs-12-ene (5) and ursolic acid lactone (6) were isolated from aerial parts of Kleinia odora and identified. Compounds 1 and 3-6 were isolated for the first time from K. odora. The triterpene constituents were investigated for antiprotozoal potential against erythrocytic schizonts of Plasmodium falciparum, intracellular amastigotes of Leishmania infantum and Trypanosoma cruzi and free trypomastigotes of T. brucei. Cytotoxicity was determined against MRC-5 fibroblasts to assess selectivity. The ursane triterpenes were found to be active against more than one type of the tested parasites, with the exception of compound 6. This is also the first report on the occurrence of ursane type triterpenes in the genus Kleinia and their antiprotozoal potential against P. falciparum, L. infantum, T. cruzi, and T. brucei.
Introduction
Protozoal infections are a worldwide health problem, particularly in developing countries [1] [2] [3] [4] , and approximately 14% of the World population are at risk of infection. Various studies have been conducted on leishmaniasis, malaria, Chagas and sleeping sickness which are considered major killing diseases [5] . The drugs currently in use mostly lack adequate efficacy, are toxic or show other liabilities, such as the need for parenteral application or high cost [6] . This reflects the need to continue searching for new and better antiprotozoal drugs. Natural products may offer good sources of leads for new drug design and discovery.
The genus Kleinia is a flowering plant comprising 40 species that are distributed in Somalia, the Middle-East, Madagascar and India [7, 8] . Three species of this genus are commonly distributed in the Southern regions in Saudi Arabia: K. odora (Forssk) DC, K. deflersii (O.Schwartz) and K. pendula (Forssk) Sch. Bip. [9] [10] [11] . Several species of Kleinia are known to be rich sources of oxygenated sesquiterpenoids such as germacrane and oplopane abrotanifolon derivatives and lupane-type tri-terpenoids [12] [13] [14] . Triterpenes comprise one of the most interesting groups of natural products due to their high potential as pharmacological agents, including leishmanicidal, trypanocidal and antiplasmodial activity [15] .
As part of our ongoing research on Saudi medicinal plant metabolites with antiprotozoal potential, triterpenoid constituents from K. odora were isolated, structurally analyzed and evaluated for antiprotozoal potential against the protozoan parasites Plasmodium falciparum, Leishmania infantum, Trypanosoma cruzi and T. brucei. To assess selectivity, cytotoxicity was determined on MRC-5 fibroblasts.
Results and Discussion

Phytochemistry
Compound 1 was isolated as a white powder. Its 13 C-NMR and DEPT spectrum (Table 1) (Table 1) showed one oxymethine proton at C-3 as a broad singlet (δ H 3.39). The proton signal at δ H 2.38 (1H, td, 11.0, 10.0, 5.5 Hz) further revealed a typical H-19β lupane structure [16] . By comparing these NMR data with previously published data [17] , compound 1 was characterized as epilupeol.
Compound 2 was also isolated as white crystals. The NMR data (Table 1) suggested a lupane skeleton. The NMR data were identical with those of epilupeol, except for the ring A signals. Compound 2 displayed a double doublet at δ H 4.47 confirming the α-orientation of the C-3 proton [18] . It also showed additional signals attributed to the presence of an acetoxy group (carbonyl signal at δ C 171.0 and methyl signals at δ C 27.9 and δ H 2.04). By comparison with previously reported data [19] , compound 2 was identified as lupeol acetate.
Compound 3 was isolated as a white powder. The 1 H-and 13 C-NMR spectra ( [21] , compound 4 was identified as brein (urs-12-ene-3β,16β-diol). The 13 C-NMR data of compound 5 (Table 1) H-NMR data of its acetate form [22] . Compound 5 was identified as 3β, 11α-dihydroxy urs-12-ene.
The NMR spectral data of compound 6 (Table 1) exhibited characteristic signals of an oleanan-28,13β-olide. The 13 C-NMR spectrum displayed resonances for a double bond at δ C 129.9 and 135.0 for C-11 and C-12, in addition to an oxygenated quaternary carbon at 91.9 and a carbonyl at 182.6 for C-13 and C-28, respectively. These data confirmed the olean-11-en,28,13β-olide structure. These results are in agreement with previously reported [23] data for ursolic acid lactone 6. Compounds 1 and 3-6 were isolated for the first time from K. odora. To the best of our knowledge, this is also the first report on the occurrence of ursane type triterpenes in the genus Kleinia. The structures are summarized in Figure 1 .
Antiprotozoal Activity
Petroleum ether and chloroform extracts of K. odora exhibited potent activity against T. brucei with IC 50 values of 0.5 µg/mL ( Table 2 ). The chloroform extract gave slightly higher selectivity (SI = 63) compared to the petroleum ether extract (SI = 39). The chloroform extract also displayed moderate activity against P. falciparum schizonts and intracellular amastigotes of L. infantum (IC 50 8 µg/mL). In comparison, the petroleum ether extract showed similar activity against P. falciparum, L. infantum and T. cruzi (IC 50 8.6, 6.8 and 5.7 µg/mL) but with lower selectivity. This motivated us to investigate the antiprotozoal activity of the isolated and identified triterpenoids from the chloroform extract.
Brein (4) and 3β, 11α-dihydroxy urs-12-ene (5) were found to be active and selective against more than one of the investigated protozoa. Brein (4) showed selective and potent activity against T. brucei (IC 50 2.3 µM, SI >27.8), with moderate side-activity against P. falciparum, L. infantum and T. cruzi (IC 50 9.3-9.9 µM) and acceptable selectivity (SI > 6.5). Compound 5 showed potent and selective activity against L. infantum (IC 50 3.2 µM, SI > 20) with some side-activity against T. cruzi and T. brucei (IC 50 8.1 and 7.9 µM, respectively, SI > 7.9). 
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Although ursolic acid (3) showed efficacy against T. brucei (IC 50 2.2 µM) comparable to that of brein (4), its effect against T. cruzi and L. infantum (IC 50 8.8 and 7.4 µM) was associated with low selectivity. Meanwhile, ursolic acid lactone 6 was devoid of any antiprotozoal activity at the highest concentration tested (64 µg/mL). The antitrypanosomal and antileishmanial activity of urosolic acid obtained herein is in consistent with the data found in literature. It has been shown to be active against T. brucei at IC 50 1.0 ± 0.2 µg/mL (2.2 µM) [24, 25] . In addition, it was also claimed active against T. cruzi with IC 50 21 µM [26] and L. donovani (IC 50 = 3.5 µg/mL) (7.6 µM) [27] . It is worthy of pointing out that in our investigation, the antiplasmodial activity of this compound (IC 50 29.7 µM) is not in agreement with previously reported data which lists IC 50 values of 3.1 µg/mL (6.8 µM) [28] and 4.9 µg/mL (10.7 µM) [29] . These divergent results may be attributed to the diversity of parasite strains, parasite load, stages of parasite life cycle or be related to differences in the experimental conditions [30] . Ursolic acid lactone 6 was reported to have activity against L. donovani (IC 50 191.52 µM) without cytotoxicity towards peripheral blood mononuclear cells [31] . In our opinion, this result was misinterpreted by the authors since the standard miltefosine under the same experimental conditions showed an IC 50 of 9.31 µM [31] ; hence, the compound should be considered as inactive. To the best of our knowledge, this is the first report on the antiprotozoal evaluation of compounds 4, 5 and 6 against P. falciparum, L. infantum, T. cruzi, and T. brucei.
Experimental
General
The 1D-NMR and 2D-NMR spectra were recorded on a Bruker AMX-400 spectrometer with tetramethylsilane (TMS) as an internal standard. Thin layer chromatography (TLC) was performed on precoated silicagel F254 plates (E. Merck, Darmstadt, Germany). All chemicals were purchased from Sigma Chemical Company (St. Louis, MO, USA).
Plant Materials
The plant Kleinia odora was collected from the South of Saudi Arabia in February 2011 and identified at the Pharmacognosy Department, College of Pharmacy, King Saud University. A voucher specimen was deposited at the Pharmacognosy Department, College of Pharmacy, King Saud University (Voucher # P-15129).
Extraction and Isolation
The air-dried and powdered aerial part of K. odora (1 kg) was extracted by maceration with 70% ethanol (4 × 2 L) at room temperature. The combined obtained ethanolic extract was filtered and evaporated at 40 °C using a rotary evaporator. The dried ethanolic extract (50 g) was subsequently redissolved in water (200 mL) and partitioned successively for several times with petroleum ether (3 × 200 mL), chloroform (3 × 200 mL) and n-butanol (3 × 200 mL) to provide the corresponding extracts. The petroleum ether extract (6 g) was subjected to column chromatography on pre-packed silica gel columns (35 mm i.d. × 350 mm) to give nine fractions. The elution was performed with a gradient of hexane-ethyl acetate (10:1) to pure ethyl acetate. TLC analysis of the fractions with anisaldehyde/sulfuric acid and heating at 100 °C allowed the analysis of the nine fractions. Fraction 1 was further purified by using a chromatotron (Harrison Research, Palo Alto, CA, USA) (silica gel 60 F 254 , layer thickness 2 mm, Merck, Darmstadt, Germany) to give compound 2 (27 mg). The elution was performed with a mobile phase composed of hexane-dichloromethane (60:40, v/v). The chloroform extract (4 g) was applied on a silica gel column and eluted with a gradient of dichloromethane-ethyl acetate (9:1) to pure ethyl acetate to give seven fractions. Fraction 1 was rechromatographed on a silica gel column (dichloromethane-acetone, 9:1) and on a RP-18 column (MeOH-H 2 O, 90:10) to produce compound 4 (48 mg) and compound 6 (21 mg). Direct crystallization of fraction 2 eluted by 30% acetone-dichlormethane gave compound 3 (35 mg 
Antiprotozoal Assay
Standard Drugs
For the different tests, appropriate reference drugs were used as positive control: tamoxifen for MRC-5, chloroquine for P. falciparum, miltefosine for L. infantum, benznidazole for T. cruzi and suramin for T. brucei. All reference drugs were either obtained from the fine chemical supplier Sigma-Aldrich, Taufkirchen, Germany (tamoxifen, suramin) or from WHO-TDR, Geneva, Switzerland (chloroquine, miltefosine, benznidazole).
Biological Assays
The integrated panel of microbial screens and standard screening methodologies were adopted as previously described [32] . All assays were performed in triplicate at the Laboratory of Microbiology, Parasitology and Hygiene at the University of Antwerp (Belgium). Plant extracts were tested at 5 concentrations (64, 16, 4, 1 and 0.25 μg/mL) to establish a full dose-titration and determination of the IC50 (inhibitory concentration 50%). The final in-test concentration of DMSO did not exceed 0.5%, which is known not to interfere with the different assays [32] . Selectivity of activity was assessed by simultaneous evaluation of cytotoxicity on a fibroblast (MRC-5) cell line. The criterion for activity was an IC50 <10 μg/mL and a selectivity index (SI) of > 4.
Antiplasmodial Activity
Chloroquine-resistant P. falciparum K 1-strain was cultured in human erythrocytes O + at 37 °C under a low oxygen atmosphere (3% O2, 4% CO2, and 93% N2) in RPMI-1640, supplemented with 10% human serum. Infected human red blood cells (200 μL, 1% parasitaemia, 2% haematocrit) were added to each well and incubated for 72 h. After incubation, test plates were frozen at −20 °C. Parasite multiplication was measured using the Malstat assay, a colorimetric method based on the reduction of 3-acetyl pyridine adenine dinucleotide (APAD) by parasite-specific lactate-dehydrogenase (pLDH) [32, 33] .
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